PDSB - PDS Biotechnology GAAP EPS of -$0.32 misses by $0.09 May, 11 2022 07:08 AM PDS Biotechnology Corporation PDS Biotechnology press release (NASDAQ:PDSB): Q1 GAAP EPS of -$0.32 misses by $0.09. Cash and cash equivalents of $58.9M For further details see: PDS Biotechnology GAAP EPS of -$0.32 misses by $0.09